When an older adult with atrial fibrillation, or Afib, stops taking an anticoagulant, it raises their risk of stroke or heart attack more than risks of bleeding, according to a new report published ...

Opens in a new tab or window A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was ...

A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose aspirin revealed a link between rivaroxaban and higher rates of major bleeding and ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

Both major and minor depression are reported in 13% of community dwelling older adults, 24% of older medical outpatients and 43% of both acute care and nursing home dwelling older adults.

Temerty Faculty of Medicine, University of Toronto, Canada. (K.G.) Women’s College Hospital, Toronto, Canada (K.G., H.A.-Q.). ICES (formerly known as the Institute ...

It is noteworthy that 11 of 12 patients with a primary outcome in the direct oral anticoagulant group received dabigatran etexilate (n=5 recurrent venous thromboembolism, n=6 major bleeding events ...